Healthcare -
Biotechnology - NASDAQ - US
$ 15.795
0.991 %
$ 1.35 B
Market Cap
-4.34
P/E
Price Target
Average
105.76%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
27.76%
Net Income
Estimate
37.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Syndax Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for SNDX of $32.5 , with forecasts ranging from
a
low of
$18 to a high of $40 .
SNDX Lowest Price Target
Wall Street Target
18 USD
13.96%
SNDX Average Price Target
Wall Street Target
32.5 USD
105.76%
SNDX Highest Price Target
Wall Street Target
40 USD
153.24%
REVENUE FORECAST
Revenue Forecast Chart SNDX
EBIT FORECAST
EBIT Forecast Chart SNDX
NET INCOME FORECAST
Net Income Chart SNDX